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Summary 
Background 
Clinical studies have reported reduced fertility in women with inflammatory bowel disease(IBD).  
Aim 
To compare fertility rates in women with IBD to those in women without IBD and assess whether the 
relative fertility differed following IBD diagnosis, flares, and surgery. 
Methods 
Women aged 15 to 44 years in 1990-2010 were identified from a UK primary care database. We 
estimated overall and age-specific fertility rates by 5-year age bands for women with and without IBD. 
We used Poisson regression to calculate fertility rate ratios(AFRR), adjusted for age, smoking and 
socioeconomic deprivation.  
Results 
There were 46.2 live births per 1,000 person-years (95% confidence interval[95%CI];44.6-47.9) in 
9,639 women with IBD and 49.3 (95%CI;49.2-49.5) in 2,131,864 without (AFRR;0.93;95%CI;0.89-
0.96). Excluding periods of contraception use the AFRR was 0.99 (95%CI;0.95-1.03). Before 
diagnosis, the AFRR for women with UC was 1.07 (95%CI;0.99-1.16) and was 0.88 (95%CI;0.81-0.97)  
for women with CD. After diagnosis, AFRRs were 0.87 (95%CI;0.82-0.94) for CD and 0.92 
(95%CI;0.86-1.00) for UC. The fertility rate was lower following flares (AFRR;0.70;95%CI;0.59-0.82) 
or surgery (AFRR;0.84;95%CI;0.77-0.92). Women with pouch and non-pouch surgery had similar 
overall fertility though the reduction after surgery was greater for pouches (AFRR;0.48;95%CI;0.23-
0.99) . 
Conclusions 
Women with Crohn’s disease have marginally lower fertility rates. These rates decreased following 
flares and surgical interventions. Fertility rates returned almost to normal when women were not 
prescribed contraception but the reduction following surgical intervention remained. As the lifetime 
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effect of pouch versus non-pouch surgery on fertility is small, the reduction post pouch surgery should 
be interpreted with caution. 
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INTRODUCTION 
Inflammatory bowel disease (IBD) is commonly diagnosed in women of childbearing age with about 
50% of women diagnosed under age 30 and 25% of women having their first pregnancy after 
diagnosis1. It is unsurprising therefore that these patients are concerned about fertility and how it may 
be affected by their disease and related medical and surgical treatments. Overall, previous research 
suggests that women with Crohn’s disease (CD) but not ulcerative colitis (UC)2 have lower live-birth 
fertility rates, although women with UC who have an ileoanal pouch report higher rates of involuntary 
infertility3,4. Many previous studies however are small and lack proper comparisons from the general 
female population without IBD. Since previous studies have generally used questionnaires to collect 
women’s reproductive history following their IBD diagnosis5–10, they may have been prone to recall 
bias. Furthermore, studies reporting reduced fertility or fecundity in women after having pouch 
surgery6–11 have not considered any decrease in the light of a woman's overall fertility plan and have 
not directly compared fertility in women following pouch surgery to women with non-pouch surgery.  
We conducted a very large cohort study of women of childbearing age to examine absolute and 
relative fertility as measured by the incidence rate of live births in women with IBD, using United 
Kingdom (UK) primary care data. Our objectives were to compare fertility in women with IBD to those 
in the general female population, to assess whether relative fertility was affected by IBD diagnosis, 
IBD flares around conception, contraceptive use, or major bowel surgery for IBD, and in women with 
UC to examine the fertility rates for women with pouch and non-pouch surgery separately.
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MATERIALS AND METHODS 
Study population 
From The Health Improvement Network (THIN), we identified all women aged 15-44 years registered 
with a general practice between 1990 and 2010. THIN is an electronic database containing routinely-
recorded diagnoses, medical events, and drug prescriptions from UK primary care and has been 
previously validated for use in pharmacoepidemiology research12. Women with IBD were defined as 
those with a medical Read code for a diagnosis of IBD in their primary care records. Each woman 
with IBD was assigned an IBD diagnosis date corresponding to the date of her first recorded IBD 
diagnosis or the date of her first prescription of 5-aminosalicylic acid, whichever was earlier. Women 
with IBD were classified as having CD if they had diagnoses specifying this condition regardless of 
whether they also had diagnoses of UC, whereas women were classified as having UC if they had a 
recording of UC only. The small proportion of women for whom neither UC or CD were coded, but 
only non-specific IBD codes are included within the overall IBD cohort only. For women with IBD we 
identified records of all major bowel surgery (intestinal resection with and without an ileoanal pouch 
formed) in their medical records. All women with no evidence of IBD in their medical records formed 
our comparison cohort, which are a good representation of the general population of women of 
childbearing age13. We identified all live births for women in the IBD and comparison cohorts over the 
study period. 
Statistical analysis 
Using Stata SE 11.0 (Stata Corp., College Station, TX, USA) we calculated the overall fertility rate as 
the number of live births per 1,000 person-years of follow-up when women were between age 15 and 
44 years and age-specific fertility rates in 5-year age bands. We used Poisson regression adjusting 
for maternal smoking (classified as ever-smoker in women ever recorded as having smoked or never-
smoker where no such record was present) and socioeconomic status (defined using quintiles of the 
Townsend Deprivation Index) to calculate both age-specific fertility rate ratios (AFRRs) comparing 
women with and without IBD and also an overall (AFRR) considering women in all age bands and 
adjusting additionally for age in 5-year bands. We repeated the same analyses for IBD subtypes (CD 
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and UC) separately. Eight hundred and ten women with codes for IBD but not CD or UC (8% of the 
overall IBD cohort) were excluded from the disease subtype analyses. 
Before and after IBD diagnosis  
To investigate whether women’s fertility relative to the general population varied in relation to their 
diagnosis of IBD, we estimated the overall and age-specific fertility rates after splitting the follow-up 
time of women with IBD into before and after the IBD diagnosis date. We estimated the AFRRs of 
women with IBD before or after diagnosis relative to the general population comparison cohort. 
IBD flares around conception 
To assess the effect of disease activity, for women with IBD we used corticosteroid prescriptions as a 
surrogate measure for flares. A flare was defined as the period following a new corticosteroid 
prescription after at least four months without such a prescription, as previously validated within this 
database14. We considered each flare to last for at least three months and remission periods were 
defined as time when women with IBD were not having a flare. We estimated the proportions of 
women with flares in each age band and the average length of flares. We calculated fertility rates in 
women with IBD separately for time periods during which conception would have occurred during an 
IBD flare (i.e. births happening 9 months after a flare), and time periods when it would have occurred 
in remission, and compared the rates to the comparison cohort. We did this for IBD overall and for CD 
and UC separately. Analyses were repeated assuming flare lengths of 1.5 and 6 months also to 
examine the sensitivity of the analysis to these assumptions. 
Fertility rates in time periods not affected by contraceptive use 
To explore the potential effect of voluntary childlessness for women with IBD, we conducted an 
additional analysis to examine the fertility rates after excluding time periods in which women were 
prescribed contraception. We assessed prescriptions of combined oral contraceptive pills, 
progestogen-only pills, progestogen-only implants and injections, copper intrauterine devices, and the 
levonorgestrel-releasing intrauterine system. We defined women as having continuous contraceptive 
use if the subsequent prescription happened within 28 days of the end of the previous one. For 
women with progestogen-only implants, copper intrauterine devices and the levonorgestrel-releasing 
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intrauterine system, we assumed the effects of these contraceptive methods lasted for the periods for 
which they were prescribed (3 years for progestogen-only implants, 10 years for copper intrauterine 
devices, and 5 years for the levonorgestrel-releasing intrauterine system) unless their medical records 
indicated they stopped these methods at earlier dates. For women with and without IBD we estimated 
fertility rates excluding the time periods during which women were covered by these contraceptives 
plus nine months after discontinuation, thus allowing for the average period of gestation. We 
calculated the AFRRs for IBD overall and for CD and UC separately, as well as for women with IBD 
following surgery. 
Major bowel surgery and pouch surgery 
Among women with IBD, we estimated fertility rates in those who had records of intestinal resections 
separately from those without intestinal resections, and compared the rates to those in the general 
population comparison cohort to ensure they were comparable with our primary analyses. To assess 
whether women’s fertility rates varied only in the time following surgery, we then separated the follow-
up time before and after a woman’s surgical period (defined as before the first ever surgical operation 
up to nine months after her last operation, thus allowing for women’s recovery from surgical 
intervention) and investigated the fertility in these periods relative to the comparison cohort. We 
repeated the same analyses for CD and UC separately. In women with UC, we conducted a 
sensitivity analysis to separately estimate the fertility rates in women who had an ileoanal pouch and 
those having a colectomy but who did not go on to have a pouch formed and to assess the rates both 
before and after surgery relative to the comparison cohort. 
Perianal disease 
We defined the presence of perianal disease as ever having a diagnosis for fistula, abscess or 
fissure and or a surgery for the disease in a woman’s medical records. We carried out an 
analysis of the overall AFRR in women with CD with or without perianal disease to assess 
whether by potentially decreasing desire to be sexually active or causing dyspareunia, it reduced 
fertility.
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RESULTS 
Study population 
We identified 9,639 women with IBD (4,475 with CD and 4,354 with UC) and 2,131,864 women 
without IBD (Table 1). The median age at start of follow-up was 30.1 years (interquartile range [IQR] 
23.5-36.8) for women with IBD and 26.8 (IQR 20.5-34.1) for women without IBD, and their median 
follow-up time was 5.7 years (IQR 2.5-10.5) and 3.5 years (1.4-7.4) respectively. In women aged 20-
24 years, 67.3% of women with IBD were using a contraceptive which was 11.0% higher than women 
without IBD and the increased use of contraceptives in women with IBD compared to women without 
IBD were also found in all other age groups (Table 1). 
Median age at IBD diagnosis was 29.3 years (IQR 22.8-37.7) being 26.9 years (IQR 21.4-35.0) for CD 
and 31.6 years (IQR 24.5-39.1) for UC. Women with UC were less likely to be from socioeconomically 
deprived areas and to be smokers compared with women with CD (Table 1). Of women with IBD 
21.9% aged 15-19 years had a flare and 32.0% of those aged 40-44 years. The average length of 
flares was 3.0 months (IQR 3.0-5.2) which was similar between women with CD and UC (Table 1). 
Overall and age-specific fertility rates and rate ratios 
We identified 3,057 live births in women with IBD (1,399 for CD and 1,390 for UC). The overall fertility 
rate was 49.3 live births per 1,000 person-years (95% confidence interval [95%CI] 49.2-49.5) in the 
general population, and was slightly lower in women with IBD (46.2, 95%CI 44.6-47.9; AFRR 0.93, 
95%CI 0.89-0.96). However, this reflected lower rates in women with CD (45.3, 95%CI 42.9-47.7; 
AFRR 0.88, 95%CI 0.83-0.92 compared with the general population) but not in women with UC (47.6, 
95%CI 45.2-50.2; AFRR 0.99, 95%CI 0.94-1.04) (Table 2). Age-specific fertility rates, however, 
showed that the relative difference in fertility rates between women with and without IBD varied by 
age (Table 2 and Figure 1a). Compared with women without IBD, women with CD had similar fertility 
rates in the 20-24, 25-29 and 40-44 year age bands but had slightly lower fertility rates in other age 
bands (Table 2). 
Fertility before and after diagnosis of IBD 
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When dividing the follow-up time in women with IBD into before or after IBD diagnosis, their overall 
fertility rate was 50.6 live births per 1,000 person-years (95%CI 47.9-53.4) before IBD diagnosis and 
43.4 (95%CI 41.4-45.5) after diagnosis (Figure 1b). Compared with women without IBD, the overall 
AFRR was 0.98 (95%CI 0.93-1.04) before IBD diagnosis but 0.89 (95%CI 0.85-0.94) after (Table 3). 
When looking at the influence of age upon this relationship, fertility in women with IBD was slightly 
higher before diagnosis than after especially before age 30 years but similar after that (Figure 1b). 
Subdividing by IBD type, compared with women without IBD, the fertility rate was statistically 
significant lower in women with CD both before and after diagnosis (AFRR 0.88 and 0.87, 95%CI 
0.81-0.97 and 0.82-0.94 for before and after CD diagnosis respectively). For UC however, the AFRR 
was slightly higher before diagnosis (AFRR 1.07, 95%CI 0.99-1.16), but lower after diagnosis (AFRR 
0.92, 95%CI 0.86-1.00). 
IBD flares around conception 
In women with IBD, the overall fertility rates were 35.6 live births per 1,000 person-years (95%CI 
30.7-41.2) in the 9 month periods following flares and 47.1 (95%CI 45.4-48.8) following periods 
without flares. The overall AFRR compared with women without IBD was 0.70 (95%CI 0.59-0.82) and 
0.95 (95%CI 0.91-0.98) respectively (Supplementary Table 1). After additionally adjusting for 
contraceptive use for women with flares, the results remained almost unchanged (Supplementary 
Table 1).The age-specific AFRRs were also lower in the periods following flares than following 
periods without flares. Similar patterns were found when examining women with CD and UC 
separately (Supplementary Table 1). These figures were not appreciably changed by varying the 
length of flares between 1.5 and 6 months. 
Fertility rates in time periods not affected by contraceptive use 
After excluding time periods during which women used contraceptives, we found similar overall fertility 
rates in women with and without IBD (fertility rates=62.8 and 63.4 live births per 1,000 person-years, 
95%CIs 63.2-63.5 and 60.5-65.2, AFRR=0.99, 95%CI 0.95-1.03) and in women with CD and UC 
separately (62.9 and 63.6 live births per 1,000 person-years, 95%CIs 59.5-66.5 and 60.2-67.3, 
AFRRs compared to women without IBD=0.95 and 1.05, 95%CIs 0.89-1.01 and 0.99-1.12 
respectively). Compared with women without IBD, the age-specific fertility rates in women with IBD 
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were slightly lower in the youngest and oldest age groups but not in middle age groups 
(Supplementary Table 2).  
Fertility in women with bowel surgery 
In women with IBD, 1,618 had intestinal resection (1,153 for CD and 452 for UC). Women’s median 
age at the 1st surgical intervention was 28.9 years (IQR 22.9-37.1) (Table 1). In those women with 
UC who had pouch surgery, the median age at which this was performed was 32.7 years (IQR 25.6-
39.2). The fertility rate was 41.8 live births per 1,000 person-years (95%CI 37.3-45.6) in the IBD 
cohort with intestinal resection but 47.2 (95%CI 45.4-49.1) in the IBD cohort without surgery (Figure 
2a). Compared with women without IBD, the overall AFRR was 5% lower in women with IBD who did 
not have surgery (AFRR 0.95, 95%CI 0.91-0.99) and was 16% lower in women with surgery (AFRR 
0.84, 95%CI 0.77-0.92) (Table 4). In addition, the fertility rate was lower after surgery (AFRR 0.81, 
95%CI 0.71-0.94) but not before surgery (AFRR 0.97, 95%CI 0.86-1.10) (Supplementary Table 3) 
when compared to those women without IBD. Fertility rates varied substantially by age (Figure 2). 
Compared with women without surgery for IBD, women with surgery had higher fertility rates at 
younger ages (age 15-19 and 20-24 years) but lower fertility rates at older ages (Figure 2a). When 
examining fertility rates before and after surgery, the fertility rates were higher in women before 
surgery especially in women before age 30 (Figure 2b). 
Fertility in women with an ileoanal pouch surgery 
For women with UC, the overall fertility rate was 36.7 live births per 1,000 person-years (95%CI 30.5-
44.2) in those who ever had a colectomy and 48.9 (95%CI 46.3-51.6) in those who did not. Compared 
with women without IBD, women with a record of surgery for UC had a 21% decreased overall fertility 
rate (AFRR 0.79, 95%CI 0.65-0.96) (Table 4) and this reflected a lower fertility rate after surgery 
(AFRR 0.70; 95%CI 0.50-0.99) (Supplementary Table 3). Though the overall fertility rate was lower, it 
was similar in women with both pouch (AFRR 0.75; 95%CI 0.55-1.01) and non-pouch surgery (AFRR 
0.82; 95%CI 0.63-1.05). The fertility rates were 23.4 live births per 1,000 person-years (95%CI 12.2-
45.0; AFRR 0.48, 95%CI 0.23-0.99 compared with women without IBD) after pouch surgery and 
32.59 (95%CI 22.35-47.52; AFRR=0.83, 95%CI 0.57-1.22) after non-pouch surgery (Supplementary 
Table 3). Compared with women without IBD, women having an ileoanal pouch had similar fertility 
rates (54.7 live births per 1,000 person-years, 95%CI 38.3-78.3; AFRR 1.08, 95%CI 0.76-1.52) before 
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the operation of colectomy (Supplementary Table 3). Though the difference between the groups was 
not significant, women with non pouch surgery had slightly lower fertility before their operations were 
completed (AFRR 0.86, 95%CI 0.61-1.21) than did those with pouches (AFRR 1.08, 95%CI 0.76-
1.52), and had higher fertility afterwards (AFRR 0.83, 95%CI 0.57-1.22) compared to those with 
pouches (AFRR 0.48, 95%CI0.23-0.99). The reduced fertility rates following bowel surgery (either 
pouch or non-pouch surgery) remained almost unchanged after excluding the time periods affected by 
contraceptive use (Supplementary Table 3). 
Perianal disease 
There were 16.5% of women with CD ever with perianal disease. When examining the role of perianal 
disease, we found that the AFRR was 0.90 (95%CI 0.79-1.02) for women with CD and perianal 
disease and 0.87 (95%CI 0.82-0.93) for women with CD but without perianal disease. 
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DISCUSSION 
Principal findings 
We have shown that over their reproductive years women with CD have slightly lower fertility rates 
than women without IBD. Women with UC however have an overall fertility rate similar to that of the 
general female population. There is also a decreased fertility rate after CD or UC diagnosis and this 
mainly affects women before age 30. There is a further decrease in fertility rates in periods following 
flares and after surgical intervention, especially following pouch surgery. Overall fertility in women with 
pouch surgery however is similar to women with non-pouch surgery. Some of the apparent adverse 
effects of pouch surgery among women with UC may therefore be due to family planning as women 
who have pouch surgery have a higher fertility rate before surgery, suggesting women electively 
complete their families before pouch surgery. Further evidence of the role of family planning and 
voluntary childlessness is provided by a comparison of fertility rates during periods when 
contraception was not prescribed. During these periods we found no significant reduction in overall 
fertility rate in women with either CD or UC; however, the fertility rate remained lower for women after 
surgery. The average diagnosis of CD is close to the average age of first birth for women in the UK 
(the average age of first birth for women was 27.0 years in 199915), and is about five years earlier 
than the average age of UC diagnosis, so it is possible that CD diagnosis more commonly interrupts 
women’s fertility plans.  
Our findings provide population-level estimates that enable women with IBD to have realistic 
comparisons of their likelihood of childbearing overall and following surgery in comparison with 
women in the general population, and will thus facilitate evidence-based (family planning) decisions 
between health care professionals and women with IBD.  
Strengths and limitations 
Because our study is based upon analysis of a large population-based cohort of women of 
childbearing age, it permits us to compare fertility rates in unbiased samples of women with IBD and 
without. This should allow our results to be generalisable to the UK population. The size of the 
database and the consequent study also allows us the power to provide reasonably precise estimates 
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for our comparisons, and to subdivide time and patient groups to separately study women of differing 
ages, with UC and CD, both with and without flares, surgery or use of contraceptives, and before and 
after surgery. A great strength of our study is that we were able to examine contraceptive use to 
minimise the potential confounding effect of voluntary childlessness. Although the small minority of 
contraception provided from family planning clinics in the UK is not coded in THIN, we believe it 
unlikely this would differ substantially between women with and without IBD. A slightly greater 
problem occurs with the recording of immunosuppression which is of obvious importance in IBD. 
Since much of this is prescribed in hospitals in the UK, and we have only GP prescription data, we are 
unable to assess any effect which it may have. 
An inevitable weakness of any large study using routinely collected data is that researchers cannot 
validate the diagnoses of individuals involved. This might appear to be a particular problem in the 
current study since in the UK IBD is diagnosed in secondary care, and we are using primary care data. 
Secondary care information, especially major medical events and medical diagnoses are however 
routinely recorded in UK primary care records following discharge communication, and the recording 
of IBD diagnoses in primary care has been shown to be highly accurate and complete16.  
Similar concerns might be raised over the recording of births since the overall fertility rate in our 
population at 49.3 live births per 1,000 persons-years is slightly lower than the average national 
general fertility rate over the same period as our study. Compared with the national average the 
fertility rates in the comparison group are consistently lower in all 5-year age groups. However the 
variation in fertility in different maternal age groups is similar to the national trend. We believe this 
could be due to the fact that general practices that contribute information to the THIN database are in 
less socioeconomically deprived areas, since previous research has shown that more people in THIN 
live in socioeconomically more affluent areas17 than the general UK population. Nevertheless, we 
cannot think of any reason why this would lead to any systematic differences in recording of live births 
between women with IBD and without IBD affecting the internal validity of our findings, particularly as 
we have included socioeconomic deprivation in our study and the differences between women with 
and without IBD are marginal. In addition, although we have an average of 3.5 years (IQR 1.4-7.4) 
follow-up data over the study period, longer for women with IBD than women without IBD, we do not 
have women’s complete reproductive history and therefore are unable to estimate the total attained 
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family size for the vast majority of the women. However, unlike most previous studies that expressed 
fertility as number of children per woman or the number of pregnant women in the population, we 
defined fertility as the number of live births per 1,000 person-years and calculated the incidence of 
live births with consideration of the different length of follow-up for women with and without IBD. If 
women included in a study have not reached the end of their reproductive lifespan, not accounting for 
age-specific follow-up time could distort comparisons because of altered family planning. 
Finally the identification of flares of IBD relies on prescriptions of corticosteroid. Though this has been 
validated (to show that flares identified really are likely to be flares), it may miss flares treated 
exclusively with drugs containing 5-aminosalicylic acid. 
Interpretation in the context of previous studies 
Our study calculates fertility rates as numbers of live births per 1,000 person-years of follow-up for 
women between ages 15 and 44 years, and not fertility (the capacity to produce offspring), or 
fecundability (the probability of becoming pregnant per month of unprotected intercourse).Using 
slightly different measurements of fertility, previous studies found that compared with women without 
the disease, women with CD have lower fertility18–20 but not women with UC10,19,21, which is consistent 
with our study. For example, Moody et al. who interviewed over 600 women with IBD in Leicester, UK 
about their reproductive histories and compared them to Census data found that women with CD had 
on average fewer live births per woman (1.2 live births per woman) than the general population but 
women with UC were more similar to the general population (1.9 live births per woman)19. In line with 
our finding that fertility was lower after diagnosis than before, the authors found more live births 
before diagnosis than after diagnosis for women with both CD and UC. This study however did not 
examine the effect of surgical intervention, nor did it present the average follow-up period for women 
with IBD. Olsen and colleagues who did examine fecundity (defined as the probability of becoming 
pregnant per month with unprotected intercourse) before and after surgical intervention by restorative 
proctocolectomy in women with UC from Sweden and Denmark10 found that compared with women in 
the general population, the fecundability was higher before diagnosis (fecundability ratio 1.46, 95%CI 
1.16-1.85) but much lower after pouch surgery (fecundability ratio 0.20, 95%CI 0.15-0.28). Our own 
findings though less extreme are similar.  
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Although a number of previous studies have suggested that women who undergo pouch surgery have 
decreased fecundability (perhaps due to adhesion formation in the pelvis)22, more recent evidence 
suggests that a higher proportion of women become pregnant spontaneously if they have 
laparoscopic rather than open pouch surgery23. Since the laparoscopic approach is uncommon in our 
study population, we were unable to differentiate the effect from open pouch surgery and therefore 
cannot inform debate on whether laparoscopic surgical intervention reduces issues of post surgical 
hypo-fertility by reducing adhesions in the pelvis. The mechanism of post pouch reduction in fertility 
however remains unclear. A US study24 found that pouch function and pregnancy-related 
complications in pregnant women with a pouch (largely with open pouch surgery) were generally 
similar to what could be expected in the general female population, suggesting that at least some of 
the previous concerns about the physical interaction of the pregnant uterus and pouch may have 
been overstated. It is therefore interesting to consider other potential mechanisms for the common 
finding of lower fertility rates in this patient group. As early as the 1970s the possibility that 
interactions between IBD and fertility might be due to frequency of intercourse rather than function of 
the reproductive organs was considered25. More recently there has been clear evidence that at least 
some of the sub-fertility in IBD may be voluntary5,20,26,27. Our findings that women with IBD (both CD 
and UC) were more likely to use contraceptives than women without IBD and had similar overall 
fertility rates after excluding time periods with contraceptive use are in line with this potential 
explanation. Moreover, our finding that the overall fertility is similar in women with pouch and non-
pouch surgery and that fertility is supra-normal in women before pouch surgery may in this context 
therefore suggest that women undergoing a pouch operation sometimes electively complete their 
family prior to surgery with an inevitable compensatory reduction in fertility thereafter. However, that 
the fertility rates following pouch and non-pouch surgery remained reduced after excluding time 
period affected by contraceptive use may suggest that surgical intervention has some biological effect 
on women’s fertility.  
Conclusion 
Our study found only slightly decreased fertility rates in women with CD and in women who had 
surgical intervention compared to the general female population, which is reassuring for women with 
IBD and their health care providers and thus provides vital information for women’s family planning. 
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We also found that these reductions in fertility were non-significant if only time when no contraception 
was prescribed were considered. Moreover, since the overall fertility rate is similar in women with 
pouch and non-pouch surgery, any potential harmful effects of pouch surgery should be interpreted 
cautiously. Women should be advised about their potential fertility according to their existing 
reproductive history, presence of acute flares and need for surgical intervention.  
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Table 1 Characteristics of study population (N=2,141,503) 
 Comparison cohort 
(n=2,131,864) 
IBD cohorta 
(n=9,639) 
CD cohort 
(n=4,475) 
UC cohort 
(n=4,354) 
 
n % n % n % n % p 
Age at start of follow-up, years 
(Median, IQR) 
26.8  20.5-34.1 30.1 23.5-36.8 28.7 22.5-35.7 31.5 25.1-37.5 <0.001 
Townsend deprivation index          
  1 (Least deprived) 439,474 20.6 2,323 24.1 998 22.3 1,132 26.0  
  2 385,636 18.1 2,071 21.5 964 21.5 944 21.7  
  3 409,860 19.2 1,881 19.5 892 19.9 845 19.4  
  4 398,434 18.7 1,635 17.0 763 17.1 712 16.4  
  5 (Most deprived) 303,222 14.2 1,088 11.3 564 12.6 430 9.9  
  Missing 195,238   9.2 641   6.7 294   6.6 291 6.7 <0.001 
Smoker ever 878,697 41.2 4,953 51.4 2,492 55.7 2,008 46.1  <0.001 
Contraceptive use, in women 
aged  
         
  15-19 years 229,382 46.3 826 60.1 476 60.6 259 55.5 <0.001 
  20-24 years 388,790 56.3 1,768 67.3 941 67.0 651 66.2 <0.001 
  25-29 years 403,636 53.6 2,338 62.9 1,174 62.1 961 63.8 <0.001 
  30-34 years 331,889 46.2 2,358 54.7 1,136 56.7 1,021 52.5 <0.001 
  35-39 years 235,309 35.2 1,838 40.8 815 41.5 874 40.8 <0.001 
  40-44 years 141,758 22.7 1,231 27.0 512 27.2 611 26.9 <0.001 
Average age at childbirth, years 
(Median, IQR) 
29.7 25.3-33.6 30.5 26.8-34.1 29.9 25.9-33.5 31.1 27.6-34.7 <0.001 
Age at IBD diagnosis, years 
(Median, IQR) 
---  29.3 22.8-37.7 26.9 21.4-35.0 31.6 24.5-39.1 <0.001 
Age at 1st bowel surgeryb, years 
(Median, IQR) 
---  28.9 22.9-37.1 28.0 22.5-35.7 31.6 24.0-40.3 <0.001 
Age at pouch surgeryc,  
years (Median, IQR) 
---  ---  ---  32.7 25.6-39.2  
IBD flares,  in women aged          
  15-19 years ---  301 21.9 192 24.4 104 22.3 <0.001 
  20-24 years ---  741 28.2 447 31.8 260 26.4 <0.001 
  25-29 years ---  1,165 31.3 661 35.0 465 30.9 <0.001 
  30-34 years ---  1,349 31.3 658 32.8 630 32.4 <0.001 
  35-39 years ---  1,398 31.1 629 32.0 706 32.9 <0.001 
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 Comparison cohort 
(n=2,131,864) 
IBD cohorta 
(n=9,639) 
CD cohort 
(n=4,475) 
UC cohort 
(n=4,354) 
 
n % n % n % n % p 
  40-44 years ---  1,456 32.0 628 33.4 771 34.0 <0.001 
Average length of IBD flares, 
months (Median, IQR) 
---  3.0 3.0-4.9 3.0 3.0-5.2 3.0 3.0-4.8 <0.001 
a 810 women with IBD but CD or UC not specified, the characteristics of which were similar to the overall IBD group; 
b Based on 1,618 women with bowel surgery (1,153 for CD and 452 for UC); 
c Based on 147 women with pouch surgery; 
IBD=inflammatory bowel disease; CD=Crohn’s disease; UC=ulcerative colitis; IQR=interquartile range 
 
23 
 
Table 2 Overall and age-specific fertility rate ratios for inflammatory bowel disease 
Age in years Comparison cohort 
(n=2,131,864) 
IBD cohort 
(n=9,639) 
CD cohort 
(n=4,475) 
UC cohort 
(n=4,354) 
No. live  
births 
Person-years No. live  
births 
Person-years AFRR (95% CI) AFRR (95% CI) AFRR (95% CI) 
15-19 30,896 1,323,753 78 4,406 0.71 (0.56-0.89) 0.73 (0.55-0.96) 0.73 (0.48-1.09) 
20-24 91,405 1,537,861 412 7,171 0.94 (0.85-1.03) 0.89 (0.78-1.02) 0.95 (0.80-1.12) 
25-29 148,831 1,795,279 922 10,623 1.02 (0.95-1.08) 0.96 (0.88-1.06) 1.10 (1.00-1.22) 
30-34 157,950 1,953,239 1,035 13,571 0.92 (0.87-0.98) 0.87 (0.80-0.96) 0.97 (0.89-1.06) 
35-39 79,349 2,030,425 520 15,092 0.87 (0.80-0.96) 0.79 (0.69-0.91) 0.96 (0.85-1.08) 
40-44 15,009 1,972,991 90 15,265 0.78 (0.62-0.98) 0.83 (0.61-1.14) 0.76 (0.56-1.02) 
Overall  
(All ages) 
523,440 10,613,550 3,057 66,128 0.93 (0.89-0.96) 0.88 (0.83-0.92) 0.99 (0.94-1.04) 
AFRR=fertility rate ratio comparing women with IBD (or CD or UC separately) to women in the comparison cohort without IBD, adjusted for maternal smoking and 
socioeconomic status (with additional adjustment for maternal age for overall fertility rate ratios);  
95%CI=95% confidence interval; IBD=inflammatory bowel disease; CD=Crohn’s disease; UC=ulcerative colitis
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Table 3 Age-specific fertility rate ratios before and after diagnoses of inflammatory bowel disease 
(IBD) (N=5,803 and 8,685 respectively) compared with women without IBD (N=2,131,864) 
Age in years Before IBD diagnosis After IBD diagnosis 
AFRR 95% CI AFRR 95% CI 
IBD cohort     
15-19 0.71 0.54-0.93 0.69 0.45-1.06 
20-24 1.03 0.91-1.17 0.84 0.72-0.97 
25-29 1.12 1.02-1.22 0.94 0.86-1.03 
30-34 0.93 0.84-1.02 0.92 0.85-0.99 
35-39 0.89 0.76-1.04 0.87 0.78-0.97 
40-44 0.84 0.58-1.23 0.75 0.56-1.00 
Overall (All ages) 0.98 0.93-1.04 0.89 0.85-0.94 
CD cohort     
15-19 0.72 0.52-0.98 0.76 0.45-1.26 
20-24 0.93 0.77-1.12 0.86 0.72-1.03 
25-29 1.02 0.88-1.17 0.93 0.82-1.05 
30-34 0.80 0.67-0.96 0.90 0.81-1.01 
35-39 0.75 0.56-1.00 0.80 0.68-0.94 
40-44 0.64 0.32-1.28 0.90 0.59-1.37 
Overall (All ages) 0.88 0.81-0.97 0.87 0.82-0.94 
UC cohort     
15-19 0.76 0.44-1.31 0.64 0.28-1.48 
20-24 1.11 0.92-1.35 0.71 0.52-0.96 
25-29 1.24 1.09-1.41 0.98 0.85-1.13 
30-34 1.01 0.89-1.15 0.94 0.84-1.06 
35-39 0.98 0.80-1.20 0.94 0.81-1.10 
40-44 0.92 0.56-1.52 0.68 0.46-1.02 
Overall (All ages) 1.07 0.99-1.16 0.92 0.86-1.00 
AFRR=fertility rate ratio comparing women before and after IBD diagnosis to women in the comparison cohort 
without IBD, adjusted for maternal smoking and socioeconomic status (with additional adjustment for maternal 
age for overall fertility rate ratios); 
IBD=inflammatory bowel disease; CD=Crohn’s disease; UC=ulcerative colitis; 95%CI=95% confidence interval
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Table 4 Age-specific fertility rate ratios for inflammatory bowel disease (IBD) with and without 
intestinal resection (N=1,618 and 8,021 respectively) compared with women without IBD 
(N=2,131,864) 
Age in years Without surgery With surgery 
AFRR 95% CI AFRR 95% CI 
IBD cohort     
15-19 0.70 0.54-0.91 0.71 0.42-1.21 
20-24 0.90 0.80-1.00 1.12 0.91-1.38 
25-29 1.03 0.96-1.11 0.94 0.80-1.09 
30-34 0.96 0.89-1.02 0.77 0.66-0.90 
35-39 0.91 0.83-1.00 0.70 0.55-0.88 
40-44 0.79 0.62-1.01 0.73 0.40-1.33 
Overall (All ages) 0.95 0.91-0.99 0.84 0.77-0.92 
CD cohort     
15-19 0.68 0.50-0.93 0.89 0.53-1.50 
20-24 0.82 0.69-0.96 1.13 0.90-1.42 
25-29 0.98 0.88-1.09 0.91 0.76-1.09 
30-34 0.90 0.81-1.01 0.81 0.68-0.96 
35-39 0.84 0.71-0.99 0.67 0.51-0.89 
40-44 0.82 0.53-1.27 0.85 0.45-1.64 
Overall (All ages) 0.89 0.83-0.95 0.85 0.77-0.94 
UC cohort     
15-19 0.82 0.52-1.31 - - 
20-24 0.94 0.79-1.12 1.05 0.63-1.73 
25-29 1.11 1.01-1.23 1.00 0.74-1.36 
30-34 1.00 0.92-1.10 0.69 0.51-0.95 
35-39 0.98 0.86-1.11 0.79 0.52-1.22 
40-44 0.83 0.60-1.14 0.16 0.02-1.13 
Overall (All ages) 1.01 0.96-1.07 0.79 0.65-0.96 
AFRR=fertility rate ratio comparing women with IBD with and without bowel surgery to women in the comparison 
cohort without IBD, adjusted for maternal smoking and socioeconomic status (with additional adjustment for 
maternal age for overall fertility rate ratios); gap in the cell indicates no outcomes. 
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IBD=inflammatory bowel disease; CD=Crohn’s disease; UC=ulcerative colitis; 95%CI=95% confidence interval
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Figure legends 
Figure 1. Age-specific fertility rates (per 1,000 person-years) for women with IBD (N=9,639) compared 
to women without IBD (N=2,131,864). The relative difference in fertility rates between women with 
and without IBD varied by age (A). The overall fertility rate was higher before IBD diagnosis than after 
but the difference varied by age (B). 
Figure 2. Age-specific fertility rates (per 1,000 person-years) for women with IBD with bowel surgery 
(N=1,618) compared to women without IBD (N=2,131,864). Fertility rates in women with bowel 
surgery for IBD varied substantially by age and were higher at younger ages but lower at older ages 
(A). Fertility rates were higher in women before surgery especially in women before age 30 (B). 
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Figure 1. Age-specific fertility rates (per 1,000 person-years) for women with IBD (N=9,639) compared to women 
without IBD (N=2,131,864) 
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Figure 2. Age-specific fertility rates (per 1,000 person-years) for women with IBD with bowel surgery (N=1,618) 
compared to women without IBD (N=2,131,864) 
